“Almost always, requests for resources require making two decisions: Should we support this business idea? and Is this proposal the right way to go about it? Most capital budgeting processes are set up to vet projects (in other words, they’re aimed at the second question, not the first). It is usually possible to carry out fairly rigorous quantitative analysis comparing the plan of action in a proposal with alternatives. It is important that this analysis be done-and it is often done ad nauseam. But our research shows that the first question, the business question, is more important and far more difficult to answer-and it is often ignored.”

Joseph L. Bowerr & Clark G. Gilbert: “From Resource Allocation to Strategy From Resource Allocation to Strategy”

Examples of our assignments include:

Acquisition Programme
DCA advised the management of a Swiss multinational corporation on the creation of a healthcare and life science strategic business unit. We subsequently identified suitable acquisition targets consistent with the company’s strategy and successfully executed the first acquisition.

DCA advised a holding group with US and UK biotechnology manufacturing facilities. We controlled the divestiture of a subsidiary whose early stage products were found to be no longer consistent with the strategic direction of the quoted parent.

Drug development tools
DCA advises central research groups of pharmaceutical companies on the acquisition of strategically important enabling technologies for their early stage drug discovery programmes.

Due Diligence
DCA advises on technology and marketing due diligence

European Biologicals Company
DCA assists the management with external collaborations and business development.

European Business Development
DCA advised the Chairman of a US healthcare group based in New York on the development of a marketing and distribution strategy for replicating the company’s domestic success in European export markets.

Licensing biotechnology
DCA advised the management of a Boston based, US biotechnology company. We advised in the early stage funding and formation of the company, assisted in the development of a number of the company’s diagnostic and therapeutic intellectual properties and arranged licensing and distribution agreements.

Intellectual Property Assignment
DCA conducted an investigation on behalf of a government agency to identify commercially attractive university research. We advised the managing board on identifying, protecting and commercially exploiting the inherent value of the intellectual property.

Interim management Assignment
Most recently assisting an overseas management group establish a European subsidiary.

Marketing and Distribution
DCA advises the management of companies in North America, Europe, Japan, and around the Pacific Rim on the exploitation of their intellectual property and the marketing and distribution of their products in export markets.

DCA advised the Directorate of a UK government-owned laboratory on the sale of one of its manufacturing facilities.

Professional practices
DCA advises the partners of professional practices on business development strategies.

Research based drug delivery company
DCA is retained to develop licensing and strategic alliance programmes for the company.

Technology Acquisition
DCA is retained by the heads of new product development in several international companies to identify technology, process and product opportunities.

Venture Capital
DCA advises risk capital and asset managers on managing their technology based investment portfolios and developing suitable exit strategies.

For further information about DCA and our activities please use the menu above. Alternatively, you can always contact us if you have a specific query.